Earnings History Data for Rubius Therapeutics, Inc. (RUBY) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. is a bio-technology company. It develops cellular therapies for the treatment of auto-immune, metabolic and other diseases. Rubius Therapeutics, Inc. is based in Cambridge, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09-08-2022 | PM | 8:00 AM ET (Aug 9) |
RUBY | Rubius Therapeutics, Inc. | 69.68 | -0.49 | -0.52 | -0.56 | Rubius Therapeutics GAAP EPS of -$0.49 beats by $0.03 [8/9/2022 8:12 AM] |
0.8079 | 0.02 (1.89%) |
0.83 | 0.04 (4.68%) |
0.65 - 24.84 | 292,005 | 470,000 | 541 | |
| 10-05-2022 | PM | 8:00 AM ET (May 10) |
RUBY | Rubius Therapeutics, Inc. | 128.97 | -0.58 | -0.57 | -0.51 | Rubius Therapeutics GAAP EPS of -$0.58 beats by $0.01 [5/10/2022 8:04 AM] |
1.48 | 0.15 (11.28%) |
1.60 | 0.27 (20.30%) |
1.18 - 29.06 | 886,626 | 1,510,671 | 763 | |
| 25-02-2022 | PM | 8:00 AM ET (Feb 25) |
RUBY | Rubius Therapeutics, Inc. | 439.44 | -0.61 | -0.58 | -0.50 | Rubius Therapeutics GAAP EPS of -$0.61 misses by $0.02 [2/25/2022 8:08 AM] |
4.95 | -0.06 (-1.20%) |
5.00 | -0.01 (-0.20%) |
4.36 - 38.71 | 324,755 | 590,000 | 203 | |
| 08-11-2021 | AH | After the close (Nov 8) |
RUBY | Rubius Therapeutics, Inc. | 1,380 | -0.55 | -0.56 | -0.51 | Rubius Therapeutics EPS beats by $0.02 [11/8/2021 4:37 PM] |
15.37 | 0.62 (4.20%) |
14.75 | 0.0 (0.00%) |
4.55 - 38.71 | 484,648 | 330,000 | 1,771 | |
|
||||||||||||||||||
| 09-08-2021 | PM | 8:00 AM ET (Aug 9) |
RUBY | Rubius Therapeutics, Inc. | 1,970 | -0.56 | -0.48 | -0.47 | Rubius Therapeutics EPS misses by $0.06 [8/9/2021 8:05 AM] |
22.80 | 1.17 (5.41%) |
21.63 | 0.0 (0.00%) |
4.20 - 38.71 | 211,774 | 260,000 | 44,911 | |
| 10-05-2021 | PM | 0:00 AM ET (May 10) |
RUBY | Rubius Therapeutics, Inc. | 2,210 | -0.51 | -0.54 | -0.60 | Rubius Therapeutics EPS beats by $0.02 [5/10/2021 8:03 AM] |
24.89 | -1.26 (-4.82%) |
26.15 | 0.0 (0.00%) |
4.20 - 38.71 | 469,521 | 470,000 | 1,916 | |
| 23-02-2021 | PM | 8:05 AM ET (Feb 23) |
RUBY | Rubius Therapeutics, Inc. | 1,020 | -0.50 | -0.54 | -0.56 | Rubius Therapeutics EPS beats by $0.03 [2/23/2021 8:07 AM] |
11.36 | -0.98 (-7.94%) |
12.35 | 0.01 (0.08%) |
3.35 - 15.99 | 365,285 | 385,362 | 1,559 | |
| 09-11-2020 | PM | 8:00 AM ET (Nov 9) |
RUBY | Rubius Therapeutics, Inc. | 369.11 | -0.51 | -0.50 | -0.59 | Rubius Therapeutics EPS misses by $0.01 [11/9/2020 8:07 AM] |
4.78 | 0.36 (8.14%) |
4.80 | 0.38 (8.60%) |
3.35 - 14.44 | 249,923 | 183,113 | 1,095 | |
|
|
||||||||||||||||||
| 10-08-2020 | PM | 8:00 AM ET (Aug 10) |
RUBY | Rubius Therapeutics, Inc. | 416.06 | -0.47 | -0.54 | -0.50 | Rubius Therapeutics EPS beats by $0.03 [8/10/2020 8:05 AM] |
5.86 | 0.68 (13.13%) |
5.42 | 0.24 (4.63%) |
3.35 - 14.44 | 231,970 | 107,891 | 968 | |
|
|
||||||||||||||||||